Oscar Health (NYSE:OSCR) Price Target Raised to $13.00

Oscar Health (NYSE:OSCR) had its target price lifted by Barclays from $11.00 to $13.00 in a research note released on Monday morning,Benzinga reports. They currently have an underweight rating on the stock.

Several other brokerages also recently commented on OSCR. Wall Street Zen downgraded shares of Oscar Health from a “hold” rating to a “sell” rating in a research report on Saturday, August 9th. Wells Fargo & Company increased their price target on shares of Oscar Health from $10.00 to $14.00 and gave the company an “underweight” rating in a report on Tuesday, October 7th. UBS Group raised their price target on shares of Oscar Health from $11.00 to $12.00 and gave the company a “sell” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Finally, Piper Sandler cut their target price on Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Six investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, Oscar Health presently has a consensus rating of “Reduce” and an average target price of $13.57.

Oscar Health Stock Up 1.5%

OSCR stock opened at $15.08 on Monday. The business has a 50 day moving average of $19.04 and a 200 day moving average of $16.87. The firm has a market cap of $3.90 billion, a PE ratio of -13.46 and a beta of 1.88. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.80. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same period in the previous year, the company posted ($0.22) earnings per share. The company’s revenue for the quarter was up 23.2% compared to the same quarter last year. Oscar Health has set its FY 2025 guidance at EPS. On average, research analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently added to or reduced their stakes in OSCR. Vanguard Group Inc. lifted its holdings in shares of Oscar Health by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company’s stock valued at $381,636,000 after buying an additional 423,184 shares during the period. T. Rowe Price Investment Management Inc. increased its position in Oscar Health by 4.1% during the first quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company’s stock valued at $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC increased its position in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. American Century Companies Inc. lifted its holdings in Oscar Health by 89.0% in the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company’s stock valued at $100,298,000 after acquiring an additional 2,495,691 shares during the period. Finally, BIT Capital GmbH boosted its position in Oscar Health by 1.1% in the first quarter. BIT Capital GmbH now owns 4,521,445 shares of the company’s stock worth $59,276,000 after purchasing an additional 47,592 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.